Publications by authors named "Yu Na Han"

Claim this Profile
T
Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Yu Na Han, Yeo Jin Choi, Sandy Jeong Rhie

Healthcare (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verapamil-containing silicone gel reduces scar hypertrophy.
Jangyoun Choi, Yu Na Han, Eun Young Rha, Hwi Ju Kang, Ki Joo Kim

Int Wound J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric Oxide Produced by the Antioxidant Activity of Verapamil Improves the Acute Wound Healing Process.
Yu Na Han, Yoon Jae Lee, Ki Joo Kim, Su Jin Lee, Jang Youn Choi

Tissue Eng Regen Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Condition of Isolation from an Adipose Tissue-Derived Stromal Vascular Fraction for the Development of Automated Systems.
Su Jin Lee, Chae Rim Lee, Ki Joo Kim, Yeon Hee Ryu, Eunjin Kim, Yu Na Han

Tissue Eng Regen Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal Growth Factor (EGF)-Like Repeats and Discoidin I-Like Domains 3 (EDIL3): A Potential New Therapeutic Tool for the Treatment of Keloid Scars.
Yeon Hee Ryu, Yoon Jae Lee, Ki-Joo Kim, Su Jin Lee, Yu-Na Han

Tissue Eng Regen Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis